Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 188

1.

Steroidal alkaloid variation in Veratrum californicum as determined by modern methods of analytical analysis.

Turner MW, Rossi M, Campfield V, French J, Hunt E, Wade E, McDougal OM.

Fitoterapia. 2019 Sep;137:104281. doi: 10.1016/j.fitote.2019.104281. Epub 2019 Aug 2.

2.

Mutagenesis of α-Conotoxins for Enhancing Activity and Selectivity for Nicotinic Acetylcholine Receptors.

Turner MW, Marquart LA, Phillips PD, McDougal OM.

Toxins (Basel). 2019 Feb 13;11(2). pii: E113. doi: 10.3390/toxins11020113. Review.

3.

Native V. californicum Alkaloid Combinations Induce Differential Inhibition of Sonic Hedgehog Signaling.

Turner MW, Cruz R, Elwell J, French J, Mattos J, McDougal OM.

Molecules. 2018 Sep 1;23(9). pii: E2222. doi: 10.3390/molecules23092222.

4.

α-Conotoxin Decontamination Protocol Evaluation: What Works and What Doesn't.

Turner MW, Cort JR, McDougal OM.

Toxins (Basel). 2017 Sep 14;9(9). pii: E281. doi: 10.3390/toxins9090281.

5.

Voting and mentally disordered offenders: a Scottish (and post-Brexit) supplementary.

Forrest AD, Turner MW, Bennett DM.

BJPsych Bull. 2016 Dec;40(6):347-348. doi: 10.1192/pb.40.6.347a. No abstract available.

6.

Scottish provisions for vulnerable witnesses.

Turner MW, Forrest AD, Bennett DM.

BJPsych Bull. 2016 Dec;40(6):347. doi: 10.1192/pb.40.6.347. No abstract available.

7.

Harpagoside Content in Devil's Claw Extracts.

Kondamudi N, Turner MW, McDougal OM.

Nat Prod Commun. 2016 Sep;11(9):1215-1216.

PMID:
30807002
8.

Cyclopamine bioactivity by extraction method from Veratrum californicum.

Turner MW, Cruz R, Mattos J, Baughman N, Elwell J, Fothergill J, Nielsen A, Brookhouse J, Bartlett A, Malek P, Pu X, King MD, McDougal OM.

Bioorg Med Chem. 2016 Aug 15;24(16):3752-7. doi: 10.1016/j.bmc.2016.06.017. Epub 2016 Jun 14.

9.

Computational exploration of a protein receptor binding space with student proposed peptide ligands.

King MD, Phillips P, Turner MW, Katz M, Lew S, Bradburn S, Andersen T, McDougal OM.

Biochem Mol Biol Educ. 2016 Jan-Feb;44(1):63-7. doi: 10.1002/bmb.20925. Epub 2015 Nov 5.

10.

European Union funded project on the development of a whole complement deficiency screening ELISA-A story of success and an exceptional manager: Mohamed R. Daha.

Würzner R, Tedesco F, Garred P, Mollnes TE, Truedsson L, Turner MW, Sommarin Y, Wieslander J, Sim RB.

Mol Immunol. 2015 Nov;68(1):63-6. doi: 10.1016/j.molimm.2015.05.003. Epub 2015 May 23. Review.

PMID:
26006049
11.

MBL2 deficiency is associated with higher genomic bacterial loads during meningococcemia in young children.

Darton TC, Jack DL, Johnson M, Borrow R, Guiver M, Kaczmarski EB, Turner MW, Klein NJ, Read RC.

Clin Microbiol Infect. 2014 Dec;20(12):1337-42. doi: 10.1111/1469-0691.12745. Epub 2014 Dec 18.

12.

An evaluation of web-based clinical practice guidelines for managing problems associated with cannabis use.

Norberg MM, Turner MW, Rooke SE, Langton JM, Gates PJ.

J Med Internet Res. 2012 Dec 7;14(6):e169. doi: 10.2196/jmir.2319.

13.

Epidural catheter connectors: a laboratory-based comparison of the Portex Tuohy-Borst and EpiFuse™ designs.

Richardson PB, Turner MW, Wilkes AR.

Anaesthesia. 2012 Oct;67(10):1119-24. doi: 10.1111/j.1365-2044.2012.07248.x. Epub 2012 Jul 16.

14.

Extubation guidelines: anaesthetists' experience and confidence.

Baxter S, Turner MW, Daubeny T.

Anaesthesia. 2012 Aug;67(8):917-8; author reply 921-2. doi: 10.1111/j.1365-2044.2012.07254.x. No abstract available.

15.

Cardiac output monitoring to guide fluid replacement in head and neck microvascular free flap surgery-what is current practice in the UK?

Chalmers A, Turner MW, Anand R, Puxeddu R, Brennan PA.

Br J Oral Maxillofac Surg. 2012 Sep;50(6):500-3. doi: 10.1016/j.bjoms.2011.08.010. Epub 2011 Sep 21.

PMID:
21940078
16.

The Portex EpiFuse epidural connector: lessons on first use in a large district general hospital.

Richardson PB, Turner MW, Callander CC.

Anaesthesia. 2011 Oct;66(10):948-9. doi: 10.1111/j.1365-2044.2011.06847.x. No abstract available.

17.

Transtracheal jet ventilation in patients with severe airway compromise and stridor.

Ahmad Y, Turner MW.

Br J Anaesth. 2011 Apr;106(4):602; author reply 602. doi: 10.1093/bja/aer042. No abstract available.

18.

Endothelial response to childhood infection: the role of mannose-binding lectin (MBL).

Charakida M, Donald AE, Leary S, Halcox JP, Turner MW, Johnson M, Loukogeorgakis SP, Okorie MI, Davey Smith G, Deanfield JE, Klein NJ.

Atherosclerosis. 2010 Jan;208(1):217-21. doi: 10.1016/j.atherosclerosis.2009.07.055. Epub 2009 Aug 8.

PMID:
19709662
19.

Laryngomalacia in a 12-year-old child after laryngeal mask use.

Sproson EL, Madden GJ, Turner MW.

J Laryngol Otol. 2009 Sep;123(9):1042-4. doi: 10.1017/S0022215109005325. Epub 2009 Apr 17.

PMID:
19371456
20.

Mannose-binding lectin is present in the infected airway: a possible pulmonary defence mechanism.

Fidler KJ, Hilliard TN, Bush A, Johnson M, Geddes DM, Turner MW, Alton EW, Klein NJ, Davies JC.

Thorax. 2009 Feb;64(2):150-5. doi: 10.1136/thx.2008.100073. Epub 2008 Nov 6.

PMID:
18988662
21.

Three-dimensional structure of conotoxin tx3a: An m-1 branch peptide of the M-superfamily.

McDougal OM, Turner MW, Ormond AJ, Poulter CD.

Biochemistry. 2008 Mar 4;47(9):2826-32. doi: 10.1021/bi702388b. Epub 2008 Jan 19.

PMID:
18205318
22.

Mannose-binding lectin in innate immunity: past, present and future.

Dommett RM, Klein N, Turner MW.

Tissue Antigens. 2006 Sep;68(3):193-209. Review.

PMID:
16948640
23.

Endotoxin immunity and the development of the systemic inflammatory response syndrome in critically ill children.

Stephens RCM, Fidler K, Wilson P, Barclay GR, Mythen MG, Dixon GLJ, Turner MW, Klein NJ, Peters MJ.

Intensive Care Med. 2006 Feb;32(2):286-294. doi: 10.1007/s00134-005-0019-z. Epub 2006 Feb 1.

PMID:
16450100
24.

Mannose-binding lectin polymorphisms in severe sepsis: relationship to levels, incidence, and outcome.

Gordon AC, Waheed U, Hansen TK, Hitman GA, Garrard CS, Turner MW, Klein NJ, Brett SJ, Hinds CJ.

Shock. 2006 Jan;25(1):88-93.

PMID:
16369192
25.

Safety of transtracheal jet ventilation in upper airway obstruction.

McLeod AD, Turner MW, Torlot KJ, Chandradeva K, Palin C.

Br J Anaesth. 2005 Oct;95(4):560-1; author reply 561. No abstract available.

26.

Role for mannose binding lectin in the prevention of Mycoplasma infection.

Hamvas RM, Johnson M, Vlieger AM, Ling C, Sherriff A, Wade A, Klein NJ, Turner MW, Webster AD.

Infect Immun. 2005 Aug;73(8):5238-40.

27.

Susceptibility to infection in patients with neutropenia: the role of the innate immune system.

Neth OW, Bajaj-Elliott M, Turner MW, Klein NJ.

Br J Haematol. 2005 Jun;129(6):713-22. Review.

PMID:
15952996
28.

Mannose-binding lectin in severe acute respiratory syndrome coronavirus infection.

Ip WK, Chan KH, Law HK, Tso GH, Kong EK, Wong WH, To YF, Yung RW, Chow EY, Au KL, Chan EY, Lim W, Jensenius JC, Turner MW, Peiris JS, Lau YL.

J Infect Dis. 2005 May 15;191(10):1697-704. Epub 2005 Apr 11.

PMID:
15838797
29.

Functional analysis of the classical, alternative, and MBL pathways of the complement system: standardization and validation of a simple ELISA.

Seelen MA, Roos A, Wieslander J, Mollnes TE, Sjöholm AG, Wurzner R, Loos M, Tedesco F, Sim RB, Garred P, Alexopoulos E, Turner MW, Daha MR.

J Immunol Methods. 2005 Jan;296(1-2):187-98. Epub 2004 Dec 15.

PMID:
15680163
30.

Mannose-binding lectin enhances phagocytosis and killing of Neisseria meningitidis by human macrophages.

Jack DL, Lee ME, Turner MW, Klein NJ, Read RC.

J Leukoc Biol. 2005 Mar;77(3):328-36. Epub 2004 Nov 29.

PMID:
15569696
31.

Impaired pulmonary status in cystic fibrosis adults with two mutated MBL-2 alleles.

Davies JC, Turner MW, Klein N; London MBL CF Study Group.

Eur Respir J. 2004 Nov;24(5):798-804.

32.

Mannose binding lectin enhances IL-1beta and IL-10 induction by non-lipopolysaccharide (LPS) components of Neisseria meningitidis.

Sprong T, Jack DL, Klein NJ, Turner MW, van der Ley P, Steeghs L, Jacobs L, van der Meer JW, van Deuren M.

Cytokine. 2004 Oct 21;28(2):59-66.

PMID:
15381182
33.

Antibodies to mannose binding lectin in patients with systemic lupus erythematosus.

Mok MY, Jack DL, Lau CS, Fong DY, Turner MW, Isenberg DA, Lydyard PM.

Lupus. 2004;13(7):522-8.

PMID:
15352424
34.

Increased incidence and severity of the systemic inflammatory response syndrome in patients deficient in mannose-binding lectin.

Fidler KJ, Wilson P, Davies JC, Turner MW, Peters MJ, Klein NJ.

Intensive Care Med. 2004 Jul;30(7):1438-45. Epub 2004 May 4.

PMID:
15127191
35.
36.

The role of mannose-binding lectin in health and disease.

Turner MW.

Mol Immunol. 2003 Nov;40(7):423-9. Review.

PMID:
14568388
37.

Anti-microbial activities of mannose-binding lectin.

Jack DL, Turner MW.

Biochem Soc Trans. 2003 Aug;31(Pt 4):753-7. Review.

PMID:
12887297
38.

Assays for human mannose-binding lectin.

Turner MW, Johnson M, Booth C, Klein N, Rolland J, Davies J.

J Immunol Methods. 2003 May 1;276(1-2):147-9. No abstract available.

PMID:
12738368
40.
41.

Mannose-binding lectin regulates the inflammatory response of human professional phagocytes to Neisseria meningitidis serogroup B.

Jack DL, Read RC, Tenner AJ, Frosch M, Turner MW, Klein NJ.

J Infect Dis. 2001 Nov 1;184(9):1152-62. Epub 2001 Sep 26.

PMID:
11598838
42.

Deficiency of mannose-binding lectin and burden of infection in children with malignancy: a prospective study.

Neth O, Hann I, Turner MW, Klein NJ.

Lancet. 2001 Aug 25;358(9282):614-8.

PMID:
11530147
43.

Mannose-binding lectin accelerates complement activation and increases serum killing of Neisseria meningitidis serogroup C.

Jack DL, Jarvis GA, Booth CL, Turner MW, Klein NJ.

J Infect Dis. 2001 Oct 1;184(7):836-45. Epub 2001 Aug 15.

PMID:
11509995
44.

Differential recognition of obligate anaerobic bacteria by human mannose-binding lectin.

Townsend R, Read RC, Turner MW, Klein NJ, Jack DL.

Clin Exp Immunol. 2001 May;124(2):223-8.

45.

Mannose-binding lectin: targeting the microbial world for complement attack and opsonophagocytosis.

Jack DL, Klein NJ, Turner MW.

Immunol Rev. 2001 Apr;180:86-99. Review.

PMID:
11414367
46.

Mannose-binding lectin: structure, function, genetics and disease associations.

Turner MW, Hamvas RM.

Rev Immunogenet. 2000;2(3):305-22. Review.

PMID:
11256742
47.

Mannose-binding lectin is a component of innate mucosal defense against Cryptosporidium parvum in AIDS.

Kelly P, Jack DL, Naeem A, Mandanda B, Pollok RC, Klein NJ, Turner MW, Farthing MJ.

Gastroenterology. 2000 Nov;119(5):1236-42.

PMID:
11054381
48.

Restricted polymorphism of the mannose-binding lectin gene of indigenous Australians.

Turner MW, Dinan L, Heatley S, Jack DL, Boettcher B, Lester S, McCluskey J, Roberton D.

Hum Mol Genet. 2000 Jun 12;9(10):1481-6.

PMID:
10888598
49.
50.

Mannose-binding lectin binds to a range of clinically relevant microorganisms and promotes complement deposition.

Neth O, Jack DL, Dodds AW, Holzel H, Klein NJ, Turner MW.

Infect Immun. 2000 Feb;68(2):688-93.

Supplemental Content

Loading ...
Support Center